← Back to Search

Behavioural Intervention

Image and video data set shown with BII stimuli. for Vasovagal Syncope

N/A

Recruiting

Led By Victoria E Claydon, PhD

Research Sponsored by Simon Fraser University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-50 minutes

Awards & highlights

Study Summary

This trial aims to understand how people with needle phobia react to emotional situations that involve needles. The study will look at how these individuals respond physically when they are in an upright position and exposed to situations

Who is the study for?

This trial is for English-speaking men and women aged 18 to 50 who either have or suspect they have a fear of needles (BII phobia) or do not. It's not open to those with heart or brain disorders, pregnant individuals, menopausal women, or anyone on heart medication.Check my eligibility

What is being tested?

The study aims to understand how people with needle phobia react physically when upright and exposed to stressful situations like seeing needles (BII stimuli) compared to neutral ones. Researchers will monitor the body's response in participants both with and without this phobia.See study design

What are the potential side effects?

There are no direct side effects from the interventions as it involves exposure to images rather than medications. However, participants may experience stress-related responses such as low blood pressure which could lead to fainting.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-50 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-50 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-50 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Orthostatic Tolerance

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Image and video data set shown with BII stimuli.Experimental Treatment1 Intervention

Participants will undergo this test on two separate days. On each day, participants will be asked to watch a series of videos and images. For this arm of the study, participants will view the BII phobia-related stimuli.

Group II: Image and video data set shown with neutral stimuli.Placebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Simon Fraser UniversityLead Sponsor

52 Previous Clinical Trials

9,525 Total Patients Enrolled

1 Trials studying Vasovagal Syncope

25 Patients Enrolled for Vasovagal Syncope

Victoria E Claydon, PhDPrincipal InvestigatorProfessor, Biomedical Physiology and Kinesiology

3 Previous Clinical Trials

68 Total Patients Enrolled

1 Trials studying Vasovagal Syncope

25 Patients Enrolled for Vasovagal Syncope

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 65 and above being enrolled in this medical study?

"Individuals aged between 18 and 50 are eligible to participate in this clinical trial."

Answered by AI

Which individuals are eligible to partake in this experimental study?

"Candidates aged between 18 and 50 with a medical history of vasovagal syncope are eligible for participation in this research. Approximately 20 individuals will be accepted into the trial."

Answered by AI

Is the registration process currently ongoing for this clinical trial?

"Per the details on clinicaltrials.gov, patient enrollment is currently closed for this particular study. Initial posting of the trial was done on March 30th, 2024, with the latest update made on March 27th, 2024. While recruitment is paused for this specific trial, there are numerous other studies welcoming participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Blood Phobia on Fainting Susceptibility

Dr. Victoria Claydon 2024. "Impact of Blood Phobia on Fainting Susceptibility". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06336031.